Making the transition from a biotech startup to a commercial enterprise takes time and effort. When a therapy is finally approved for sale, that effort pays off.
New challenges follow FDA approval, such as finding appropriate large-scale pharma logistics solutions to get the therapy into the hands of patients.
Biotech startups may find that general logistics providers have trouble meeting the demands of pharma logistics. The requirements of transporting medications to hospitals often mean developing specialized processes and facilities.
There are distinctions between what's needed for biotech startups and a full-scale pharmaceutical enterprise. Biotech startups have low-volume shipments, but they require extra oversight due to the highly controlled nature of pre-approved clinical therapies. Some general logistics providers can handle smaller shipments and basic cold-chain needs with significant manual coordination, though biotech startups often benefit from specialized providers even at this stage due to the regulatory oversight required for clinical-phase therapies.
However, as the biotech company matures, it will need pharma logistics solutions that match its expanded needs. Larger volume shipments and increased frequency of shipments are already a challenge. Pharma logistics also requires ongoing compliance with industry and federal regulations at scale.
When a general logistics provider lacks the specialized processes required for transporting medications, it leads to major challenges for the manufacturer.
Poor insulation and lack of proper refrigerated trucks and storage can lead to temperature excursions that render medication ineffective or, in some cases, unsafe for patient use. A weak chain of custody and poor visibility raise questions about medication safety and security, and may put the manufacturer in violation of regulatory requirements. In addition, manual workflows and a lack of automation can cause delays in treatment for patients who need prompt care.
Biotech startups may find that they need shipping partners capable of providing a complete network for transport, storage, and monitoring of their products. Biopharma logistics involves much more than the shipment of medical therapies.
Specialized shippers can provide reliable pharma logistics solutions for startup biotech companies. These distributors have established processes for cold chain handling and chain of custody, including the ability to keep treatments within tightly controlled temperature ranges from ultra-cold to cryogenic.
Beyond temperature control, these specialized shipping partners are familiar with the compliance requirements for transporting biotech therapies. From using data loggers to monitor for temperature excursions during transport to providing expedited shipping for time-sensitive therapies, cold chain shippers help support on-time and intact delivery.
Biotech companies may need more than a shipper for their commercial enterprise. Growing biotech startups may not have a strong transportation network built up yet. This is where a specialty 3PL with biotech expertise can add significant value.
These providers offer comprehensive pharma logistics solutions by planning networks, arranging storage, and managing shipments. A specialty 3PL can maintain prompt shipments at scale within required temperature ranges, and it can also provide temperature-controlled storage and monitoring throughout the transport process.
This comprehensive oversight is made possible by an established network combined with ownership of refrigerated trucks and cryogenic storage vessels. Modern biotech pharma logistics networks rely on software at every stage of the process, including dock scheduling systems. These shippers rely on real-time status updates and warehouse coordination tools to ensure that unloaded shipments are inventoried and placed in cold storage immediately.
Before the first order is taken, biotech startups need to think about their logistics process. Develop a plan for moving the product from the facility to the distribution center and then to the patient, and test that plan until you are confident in its reliability.
Developing a biopharma logistics solution before commercial sales take off requires extra effort early on, but it pays dividends later. Having a shipping partner and proven process in place to bring therapies from the manufacturing facility to the patient avoids unwanted stress and bottlenecks.
Even biotechs in the earliest stages of commercial manufacture can develop standard operating procedures (SOPs), find a logistics partner, and start evaluating software to help maintain monitoring compliance.
In the biotech industry, logistics data cannot remain siloed within warehouse and transportation departments. Cross-functional infrastructure is necessary to ensure that all relevant teams have access to information about biotech shipments.
Quality control teams need to be informed of potential temperature excursions and receive confirmation that the chain of custody was followed. Regulatory teams require audit reports and validated, traceable data for each shipment and batch of medication. Supply chain and commercial teams also need visibility into whether shipments are arriving on time and how much inventory is available to meet demand.
Building a reliable pharma logistics solution requires careful research into shipping and cold storage practices. The following answers offer a starting point.
Since biotech startups are just beginning the commercialization of their therapies, a specialized 3PL is often the first key partner in developing pharma logistics solutions. A specialized 3PL can be your partner in developing a repeatable workflow for shipping medical therapies at scale and within set temperature ranges.
Establishing a budget for pharma logistics depends on many factors. Biotech startups should consider the complexity of transporting their therapies, including the regulatory requirements and temperature controls involved. There will also be a higher initial cost during the commercialization stage, when the biotech transitions from clinical trial logistics to full-scale commercial sales and delivery.
Generalist shippers may be sufficient when biotechs are still sending low-volume shipments and have not yet entered the complexities of commercial sales. As a biotech company scales up to larger, more frequent shipments, it benefits from the established network of a pharma-specialized 3PL. When regulatory compliance becomes stricter, a specialized 3PL can provide the added oversight through existing digital monitoring software and documented handoffs.
Biotech logistics is an industry filled with regulatory and time-sensitive challenges that can affect shipping success. Turn to Opendock's digital scheduling software to reduce missed deadlines, route temperature-sensitive shipments to cold-receiving doors, and gain real-time visibility at the dock.